Skip to main content
. 2024 Aug 22;15(4):1723–1745. doi: 10.21037/jgo-24-426

Table 2. Results of the heterogeneity test and the horizontal pleiotropy test.

Outcome Genes MR_pleiotropy_test Q_P value MR_heterogeneity P value
Pancreatic cancer (bbj-a-140) RECQL 0.89 0.49
AP2B1 0.04 0.06
MVP 0.70 0.33
EIF2AK2 0.84 0.78
BCAS1 0.83 0.31
ENO1 >0.99 0.36
MCM6 0.32 0.78
PSEN1 >0.99 0.75
XPO1 >0.99 0.98
LYZ 0.27 0.006
SEC14L2 >0.99 0.70
PYGB 0.18 0.06
CORO1C >0.99 0.93
ACTR3 0.91 0.74
STAT1 0.92 0.04
SLC25A12 >0.99 0.94
ATP8A1 0.99 0.43
PALLD 0.56 0.005
ACTN4 0.98 0.81
CAP1 >0.99 0.86
RAP1GAP2 0.64 0.46
MYH11 >0.99 0.86
LCP1 0.92 0.07
KIF23 0.72 0.04
TMOD3 0.38 0.001
BRCA2 0.99 0.96
PML 0.95 0.12
CDC42BPA 0.99 0.18
RALB 0.99 0.52
SCD5 0.47 0.009
CCNA2 0.97 0.75
ITGB1 0.90 0.36
ALB >0.99 0.79
PSMD1 >0.99 0.50
SPATS2L 0.16 0.05
KIF13B 0.81 0.47
ECI2 0.27 0.31
INF2 0.39 0.09
HSPA1B 0.60 <0.001

MR, Mendelian randomization.